Journey Medical (DERM) Other Non-Current Liabilities (2020 - 2023)
Journey Medical (DERM) posted Other Non-Current Liabilities of $1.5 million for Q2 2023, up 2.76% on a QoQ basis from $1.4 million in Q1 2023, and down 60.87% year-over-year from $3.8 million in Q2 2022.
Journey Medical (DERM) Other Non-Current Liabilities (2020 - 2023) Analysis & Trends
Journey Medical's Other Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $1.5 million for Q2 2023.
- Quarterly Other Non-Current Liabilities fell 60.87% year-over-year to $1.5 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $1.5 million (down 60.87% YoY) and the FY2022 annual result came in at $1.4 million, down 61.07% from the prior year.
- Other Non-Current Liabilities was $1.5 million for Q2 2023 at Journey Medical, up from $1.4 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $8.1 million in Q4 2020 and bottomed at $1.4 million in Q3 2022.
- A 4-year average of $3.3 million and a median of $3.6 million in 2021 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2021 — Other Non-Current Liabilities tumbled 55.43% — and 2022, when it slumped 68.52%.
- Journey Medical's Other Non-Current Liabilities stood at $8.1 million in 2020, then tumbled by 55.43% to $3.6 million in 2021, then slumped by 61.07% to $1.4 million in 2022, then increased by 5.52% to $1.5 million in 2023.
- Business Quant data shows DERM's Other Non-Current Liabilities at $1.5 million in Q2 2023, $1.4 million in Q1 2023, and $1.4 million in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Journey Medical | 179.67 Mn | 152.45 Mn | 9.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 1.49 Mn |
| Mar 31, 2023 | 1.45 Mn |
| Dec 31, 2022 | 1.41 Mn |
| Sep 30, 2022 | 1.37 Mn |
| Jun 30, 2022 | 3.81 Mn |
| Mar 31, 2022 | 3.72 Mn |
| Dec 31, 2021 | 3.63 Mn |
| Sep 30, 2021 | 4.37 Mn |
| Dec 31, 2020 | 8.14 Mn |